2nd Quarter - Report

FEDERAL STRATEGY CONSULTING for WELLDOC COMMUNICATIONS INC

Period 2nd Quarter 2014 Filed Jul 17, 2014 Signed by Julie P. Pawelczyk

Official filing
Firm
FEDERAL STRATEGY CONSULTING
Client
WELLDOC COMMUNICATIONS INC
Income
$10,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Medical/Disease Research/Clinical Labs MED

HR 962 / S 452 - Medicare Diabetes Prevention Act of 2013; HR 1074 / S 539 - National Diabetes Clinical Care Commission Act; HR 1257 - Preventing Diabetes in Medicare Act; HR 1274 / S 945 - Access to Quality Diabetes Education Act of 2013; S 557 - Medication Therapy Management Empowerment Act; HR 3322 - Eliminating Disparities in Diabetes Prevention, Access and cAre Act of 2013; HR 2845 / S 1935 - Diabetic Testing Supply Access of 2013/14; H.R. 3591 - Minority Diabetes Initiative Act; HR 2415 / S 1184 - Treat and Reduce Obesity Act of 2013; and S 596 - Fostering Independence Through Technology Act of 2013.

LobbyistCovered position, as disclosed
JULIE P PAWELCZYK —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 1257 (113th), H.R. 3591 (113th), H.R. 1274 (113th), H.R. 3322 (113th), H.R. 1074 (113th), H.R. 2845 (113th), H.R. 2415 (113th), H.R. 962 (113th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.